Information  X 
Enter a valid email address

RELX PLC (REL)

  Print      Mail a friend       Annual reports

Wednesday 01 May, 2019

RELX PLC

Director/PDMR Shareholding

RNS Number : 7903X
RELX PLC
01 May 2019
 

ISSUED ON BEHALF OF RELX PLC

Director/PDMR Shareholdings

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Henry Udow

2

 

Reason for the notification

a)

 

Position/status

PDMR

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

RELX PLC

b)

 

LEI

549300WSX3VBUFFJOO66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 14 51/116p each ('Ordinary Shares')



Identification code

ISIN: GB00B2B0DG97



b)

 

Nature of the transaction

Exercise of an option over Ordinary Shares under the RELX Group plc Executive Share Option Scheme 2003. The option price payable on exercise was £5.39 per share.

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




£5.39

25,831







d)

 

Aggregated information




- Aggregated volume

25,831



- Price

£5.39



e)

 

Date of the transaction

2019-04-29

f)

 

Place of the transaction

 Outside of a trading venue

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 14 51/116p each ('Ordinary Shares')



Identification code

ISIN: GB00B2B0DG97



b)

 

Nature of the transaction

 

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




£17.590000

50,831







d)

 

Aggregated information




- Aggregated volume

50,831



- Price

£17.590000



e)

 

Date of the transaction

2019-04-29

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 14 51/116p each ('Ordinary Shares')



Identification code

ISIN: GB00B2B0DG97



b)

 

Nature of the transaction

Exercise of an option over Ordinary Shares under the RELX Group plc Executive Share Option Scheme 2003. The option price payable on exercise was €5.832 per share.

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




€5.832

26,538







d)

 

Aggregated information




- Aggregated volume

26,538



- Price

€5.832



e)

 

Date of the transaction

 

2019-04-29

f)

 

Place of the transaction

 

 

Outside of a trading venue

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 14 51/116p each ('Ordinary Shares')



Identification code

ISIN: GB00B2B0DG97



b)

 

Nature of the transaction

 

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




€20.395000

51,538







d)

 

Aggregated information




- Aggregated volume

51,538



- Price

€20.395000



e)

 

Date of the transaction

 

2019-04-29

f)

 

Place of the transaction

 

Euronext Amsterdam Stock Exchange (XAMS)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLLFISERILIIA

a d v e r t i s e m e n t